PMID- 24077781 OWN - NLM STAT- MEDLINE DCOM- 20150723 LR - 20211021 IS - 1435-5922 (Electronic) IS - 0944-1174 (Linking) VI - 49 IP - 10 DP - 2014 Oct TI - Immunoregulatory function of PIR-A/B+ DCs in the inflammatory responses of dextran sodium sulfate-induced colitis. PG - 1367-77 LID - 10.1007/s00535-013-0879-x [doi] AB - BACKGROUND: Dendritic cells (DCs) may play an important role in forms of inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis. DCs are generally recognized as initiators of acquired immunity and also serve as regulators of both innate and acquired immunity. We used the animal model of colitis induced by dextran sodium sulfate (DSS), and examined whether DCs prepared from the colon show immunoregulatory roles in the termination of DSS-induced colitis. METHODS: C57BL/6 mice exposed to DSS for 5 days developed acute colitis. DCs were isolated from the large intestinal lamina propria, and then analyzed for phenotypical, functional, and genetic data. RESULTS: Only PIR-A/B(low) conventional DCs (cDCs) were detected in the steady state. However, after the treatment of DSS, PIR-A/B(high) cDCs appeared and gradually increased from day 5 to day 7, at which time the DSS-induced colitis was terminated. Then, allogeneic mixed leukocyte reaction (MLR) was performed. The stimulatory activity of PIR-A/B(high) cDCs obtained on day 7 was very low, and the addition of PIR-A/B(high) cDCs suppressed the T cell proliferation in MLR, indicating the immunoregulatory role of PIR-A/B(high) cDCs. The immunoregulatory role of PIR-A/B(high) cDCs was confirmed by the in vivo transfer experiment, showing their therapeutic effect on DSS-induced colitis. The message level of TGFbetai was significantly higher in PIR-A/B(high) cDCs, while that of IFN-gamma was highly upregulated in PIR-A/B(low) cDCs, being well in accordance with the fact that PIR-A/B(high) cDCs showed a suppressive function against activated T cells. CONCLUSION: PIR-A/B(high) cDCs showed a suppressive function against activated T cells by producing inhibitory cytokines. FAU - Kurishima, Akiko AU - Kurishima A AD - Division of Gastroenterology and Hepatology, Third Department of Internal Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi, Osaka, 570-8506, Japan, kurishia@takii.kmu.ac.jp. FAU - Inaba, Muneo AU - Inaba M FAU - Sakaguchi, Yutaku AU - Sakaguchi Y FAU - Fukui, Toshiro AU - Fukui T FAU - Uchida, Kazushige AU - Uchida K FAU - Nishio, Akiyoshi AU - Nishio A FAU - Nomura, Shosaku AU - Nomura S FAU - Okazaki, Kazuichi AU - Okazaki K LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20130929 PL - Japan TA - J Gastroenterol JT - Journal of gastroenterology JID - 9430794 RN - 0 (Receptors, Immunologic) RN - 9042-14-2 (Dextran Sulfate) SB - IM MH - Adoptive Transfer MH - Animals MH - Colon/immunology MH - Dendritic Cells/*immunology/transplantation MH - Dextran Sulfate MH - Disease Models, Animal MH - Female MH - Inflammatory Bowel Diseases/chemically induced/*immunology/pathology/therapy MH - Lymphocyte Culture Test, Mixed/methods MH - Mice, Inbred BALB C MH - Mice, Inbred C57BL MH - Receptors, Immunologic/analysis EDAT- 2013/10/01 06:00 MHDA- 2015/07/24 06:00 CRDT- 2013/10/01 06:00 PHST- 2013/01/21 00:00 [received] PHST- 2013/09/02 00:00 [accepted] PHST- 2013/10/01 06:00 [entrez] PHST- 2013/10/01 06:00 [pubmed] PHST- 2015/07/24 06:00 [medline] AID - 10.1007/s00535-013-0879-x [doi] PST - ppublish SO - J Gastroenterol. 2014 Oct;49(10):1367-77. doi: 10.1007/s00535-013-0879-x. Epub 2013 Sep 29.